ASND — Ascendis Pharma A/S Balance Sheet
0.000.00%
Last trade - 00:00
- $7.84bn
- $8.11bn
- €266.72m
- 31
- 17
- 86
- 41
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 592 | 719 | 682 | 735 | 399 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 5.41 | 7.34 | 23.2 | 25.6 | 55.8 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 611 | 740 | 806 | 923 | 703 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 45.1 | 108 | 126 | 129 | 111 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 677 | 980 | 1,085 | 1,090 | 826 |
Accounts Payable | |||||
Payable / Accrued | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 48 | 52.8 | 100 | 171 | 197 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 79.6 | 141 | 201 | 826 | 971 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 597 | 839 | 884 | 263 | -146 |
Total Liabilities & Shareholders' Equity | 677 | 980 | 1,085 | 1,090 | 826 |
Total Common Shares Outstanding |